Built to provide research that’s more actionable and strategically valuable, The Business Research Company’s 2026 market reports include market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, broader supply chain intelligence, emerging startup tracking, and in-depth product insights.
Complete Blood Count Device Market Forecast: Value Set To Climb From $4.58 Billion To $5.76 Billion
The market for complete blood count devices has shown robust expansion in size over recent years. This market is forecast to increase from $4.33 billion in 2025 to $4.58 billion in 2026, achieving a compound annual growth rate (CAGR) of 6.0%. The historical growth can be primarily ascribed to the expansion of clinical diagnostic testing volumes, heightened automation in hospital laboratories, the increasing burden of chronic diseases, the widespread availability of standardized blood testing protocols, and a rising demand for routine health screenings.
The complete blood count device market is anticipated to undergo significant expansion in the coming years. Its valuation is projected to reach $5.76 billion in 2030, demonstrating a compound annual growth rate (CAGR) of 5.9%. This market expansion throughout the forecast period stems from factors such as the increasing integration of decentralized diagnostics, heightened investments in intelligent laboratory infrastructure, an escalating need for swift diagnostic outcomes, the broadening scope of preventive healthcare screenings, and continuous progress in hematology technology. Noteworthy trends for the forecast duration encompass the increasing deployment of automated hematology analyzers, an escalating requirement for point-of-care complete blood count devices, the expanding incorporation of AI-driven diagnostics, the growth of high-throughput laboratory systems, and a more pronounced focus on diagnostic precision and speed.
Get A Free Sample Report With In-Depth Market Insights:
Complete Blood Count Device Market Development Factors: What’s Supporting Demand?
The increasing occurrence of blood disorders is anticipated to boost the expansion of the complete blood count device market. These conditions are health issues that interfere with the production, operation, or structure of blood cells, leading to compromised blood function. The uptick in blood disorders is connected to the rising incidence of lifestyle-related ailments, where factors like inadequate diet, lack of physical activity, and stress contribute to issues such as anemia and blood clotting problems. A complete blood count (CBC) device assists in detecting blood disorders through the examination of vital blood components and the identification of irregularities, enabling medical professionals to spot clotting conditions and provide swift and accurate treatment. For instance, in May 2024, according to the Canadian Cancer Society, a Canada-based organization, 4,100 individuals were diagnosed with multiple myeloma (a type of blood cancer), while 1,750 succumbed to the disease. Consequently, the rising prevalence of blood disorders is fueling the growth of the complete blood count device market.
Complete Blood Count Device Market Segment Outlook: Which Categories Are Growing Fastest?
The complete blood count device market covered in this report is segmented –
1) By Device Type: Automated Blood Count Analyzers, Manual Blood Count Analyzers, Point-Of-Care Testing Devices, Hematology Analyzers
2) By Test Type: White Blood Cell Count (WBC Or Leukocyte Count), White Blood Cell (WBC) Differential Count, Red Blood Cell Count (RBC Or Erythrocyte Count), Hematocrit (Hct), Hemoglobin (Hbg), Platelet Count, Mean Platelet Volume (MPV), Mean Corpuscular Hemoglobin (MCH), Other Test Types
3) By Technology: Impedance Technology, Laser-Based Technology, Flow Cytometry, Microscopy
4) By Distribution Channel: Direct Sales, Online Sales, Third-Party Distributors, Laboratory Equipment Suppliers
5) By End-User: Hospital, Diagnostic Laboratories, Research Institutes, Other End-Users
Subsegments:
1) By Automated Blood Count Analyzers: 3-Part Differential Analyzers, 5-Part Differential Analyzers, 6-Part And Above Differential Analyzers, Integrated Hematology Systems, High-Throughput Lab Analyzers
2) By Manual Blood Count Analyzers: Hemocytometers, Microscopes For Manual Differential, Manual Cell Counters, Staining Kits And Reagents
3) By Point-of-Care Testing Devices: Portable Hematology Analyzers, Handheld Complete Blood Count (CBC) Devices, Fingerstick Blood Test Devices, Rapid Diagnostic Complete Blood Count (CBC) Kits
4) By Hematology Analyzers: Low-Volume Hematology Analyzers, Mid-Volume Hematology Analyzers, High-Volume Hematology Analyzers, Veterinary Hematology Analyzers, Reagent-Free Analyzers
Complete Blood Count Device Market Transformation Trends: What Innovations Are Driving Change?
Leading companies in the complete blood count device market are concentrating on creating advanced products, such as compact hematology analyzers, to offer more precise, quicker, and economical solutions for point-of-care testing. Compact hematology analyzers are mobile, simple-to-use instruments that deliver fast, accurate complete blood count (CBC) outcomes with minimal sample volume, rendering them ideal for point-of-care applications, thereby boosting diagnostic precision, operational effectiveness, and user convenience while remaining cost-efficient and straightforward to maintain. For example, in June 2024, HORIBA, a Japan-based analytical and measurement technology firm, unveiled the Yumizen H550E and H500E hematology analyzers. These compact instruments incorporate erythrocyte sedimentation rate (ESR) testing alongside complete blood count (CBC) and 5-part differential (DIFF) analysis, employing HORIBA’s patented CoRA (correlated rouleaux analysis) technology to provide thorough results from whole blood samples in just 60 seconds.
Complete Blood Count Device Market Top Companies Driving Competitive Growth
Major companies operating in the complete blood count device market are Abbott Laboratories, Siemens Healthineers, Mindray Medical International Limited, Beckman Coulter Inc., Sysmex Corporation, Horiba Ltd., Nihon Kohden Corporation, Agappe Diagnostics Ltd., Trivitron Healthcare Pvt. Ltd., HemoCue AB, EKF Diagnostics Holdings plc, Erba Mannheim, Boule Diagnostics AB, Biosystems S.A., Diatron MI Zrt., Labtron Equipment Ltd., Microlab Instruments Co. Pvt. Ltd., URIT Medical Electronic Co. Ltd., Roche Diagnostics, Ortho Clinical Diagnostics, BioSystems Diagnostics Pvt. Ltd., Drew Scientific (subsidiary of EKF), Analyticon Biotechnologies GmbH, Rayto Life and Analytical Sciences Co. Ltd.
View The Full Complete Blood Count Device Market Report:
Complete Blood Count Device Market Global Footprint: Which Region Leads The Industry?
North America was the largest region in the complete blood count device market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the complete blood count device market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
